SLU-PP-332 in the United Kingdom

Legal status, what it is, and the listed suppliers in the United Kingdom that list it.

Legal status in the United Kingdom

Not an approved medicine.

As understood at 2026-09-22. Verify with the MHRA.

What SLU-PP-332 is

SLU-PP-332 is a synthetic small molecule, not a peptide. It is an agonist of the estrogen-related receptors (ERR alpha, beta and gamma), a family of nuclear receptors involved in mitochondrial and oxidative metabolism gene programmes, and was made as a research tool compound. It has a page here because several listed suppliers sell it alongside their peptides.

Full SLU-PP-332 page: targets and research →

Listed suppliers in the United Kingdom

1 of the 10 suppliers we list in the United Kingdom list SLU-PP-332. Listed, not endorsed: each row is the supplier’s own stated terms.

XL Peptides United Kingdom All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.

Clinical Research

Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study

Bonanni R, Falvino A, Matticari A, et al. (2025). Frontiers in Physiology. in-vitro muscle biopsies from 20 women undergoing hip replacement (10 active, 10 inactive); primary myoblasts from the inactive group treated in culture